Angina Pectoris News and Research

RSS
NOBLE study shows superiority of CABG over PCI for treatment of left main coronary artery disease

NOBLE study shows superiority of CABG over PCI for treatment of left main coronary artery disease

New generation drug eluting stents show lower efficacy than contemporary BMS, study shows

New generation drug eluting stents show lower efficacy than contemporary BMS, study shows

miRNAs may improve risk prediction in CAD

miRNAs may improve risk prediction in CAD

Ticagrelor drug shows minor added benefit for patients with history of myocardial infarction

Ticagrelor drug shows minor added benefit for patients with history of myocardial infarction

Aralez resubmits NDA package for YOSPRALA to FDA

Aralez resubmits NDA package for YOSPRALA to FDA

Sleeping too much or too little increases risk of dying from heart disease

Sleeping too much or too little increases risk of dying from heart disease

FDA-approved, once-daily 24-hour aspirin now available for prevention of stroke and acute cardiac events

FDA-approved, once-daily 24-hour aspirin now available for prevention of stroke and acute cardiac events

Second-line bosutinib offers ‘durable’ response for chronic phase CML patients

Second-line bosutinib offers ‘durable’ response for chronic phase CML patients

New Haven Pharmaceuticals' DURLAZA drug delivers sustained antiplatelet control for full 24 hours

New Haven Pharmaceuticals' DURLAZA drug delivers sustained antiplatelet control for full 24 hours

Full clinical trial feasible in refractory chronic angina pectoris

Full clinical trial feasible in refractory chronic angina pectoris

Antihypertensive therapy decreases risk of mortality, CV events, strokes in older adults

Antihypertensive therapy decreases risk of mortality, CV events, strokes in older adults

Cardium announces review in Journal of Cardiovascular Pharmacology finds gene therapy for subset of heart disease patients ‘highly warranted’

Cardium announces review in Journal of Cardiovascular Pharmacology finds gene therapy for subset of heart disease patients ‘highly warranted’

Cardium reports positive results from Generx Ad5FGF-4 Phase 3 study for treatment of myocardial ischemia

Cardium reports positive results from Generx Ad5FGF-4 Phase 3 study for treatment of myocardial ischemia

Micell Technologies presents DESSOLVE I and II trial data at EuroPCR conference

Micell Technologies presents DESSOLVE I and II trial data at EuroPCR conference

Endo acquires worldwide rights to Zogenix' sumatriptan injection

Endo acquires worldwide rights to Zogenix' sumatriptan injection

Treating long wait-times dictate long-term success of spinal cord stimulation therapy

Treating long wait-times dictate long-term success of spinal cord stimulation therapy

POZEN reports total revenue of $4.7 million for fourth quarter 2013

POZEN reports total revenue of $4.7 million for fourth quarter 2013

Long-term exposure to particulate matter linked with increased risk for heart attack

Long-term exposure to particulate matter linked with increased risk for heart attack

Psychotic symptoms alone denote medical health risk

Psychotic symptoms alone denote medical health risk

High-intensity exercise protective against coronary heart disease

High-intensity exercise protective against coronary heart disease